Announcement.
WEBINAR: No more missed pathogens. One metagenomic method for all.
Enzymes that Unlock
Your Next Discovery
0
Viral Bioprocessing

New Poster: Quantification Challenges of Chromatin—Associated Host Cell DNA: An Underestimated Risk

Introduction

Are you significantly underestimating chromatin-associated host-cell DNA?

Across viral vector and protein-based manufacturing, nearly every process team tracks host-cell DNA. But a growing body of evidence suggests something uncomfortable: your numbers might be off by an order of magnitude—and not in your favour.

Download the poster here

Presented at: Advanced Therapies USA, Nov 2025

In this new technical poster, Quantification Challenges of Chromatin-Associated Host Cell DNA: An Underestimated Risk, our R&D team explores a problem that has quietly influenced DSP outcomes for years:

Chromatin fragments don't behave like “DNA” — and your assays might not notice.

Chromatin is released in complex, protein-bound structures. These aren’t just difficult to clear during purification—they can also be nearly invisible to standard intercalating-dye assays, including PicoGreen.

The poster shows that disrupting histone–DNA interactions and fragmenting DNA can increase measured signal more than 20-fold—meaning what looks like “low DNA contamination” may simply be poor chromatin accessibility, not real process cleanliness .

Why this matters for Process Dev, MSAT, and QA teams:

If quantification underestimates the true impurity level, downstream decisions become risky:

  • You may believe nuclease treatment wasn’t needed when it actually was.
  • Inefficient nucleases may appear effective simply because the DNA not digested was never fully detected.
  • DSP capacity can be reduced due to undetected impurity load.

The poster walks through how fragmentation affects detectability, how some partially digested chromatin left by some nuclease can remain undetected, and how salt conditions play into the picture—without requiring any change to your analytical platform.

Live Q&A

You can ask any questions about this poster with this a Live AI-based Q&A. You can ask the Q&A to respond in any way you want, including highly technical or simplified language. You can ask it to respond in most languages. It accesses a model specifically trained on this poster content with notes and additional information from data referenced using a model in ChatGPT. You will need to log into a ChatGPT account, but give the Live Q&A a try here.

Subscribe to Newsletter.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
For Customer Support
For  Technical Support
Metagenomics

How an Accidental Error Helped Unlock Clinical Metagenomics [Video]

Explore the origins, challenges and breakthroughs shaping clinical metagenomics in this three-part series with Professor Justin O’Grady.
Read More
Viral Bioprocessing

CAR-T Breakthroughs and the Emerging Potential of In Vivo Therapy

Explore the latest CAR T advancements and the promising future of in vivo technologies. Discover their potential impact on cancer treatment.
Read More
Viral Bioprocessing

New Poster: Quantification Challenges of Chromatin—Associated Host Cell DNA: An Underestimated Risk

Presented at Advanced Therapies USA, Nov 2025 - Learn if you are significantly underestimating chromatin-associated host-cell DNA?
Read More
Lorem ipsum dolor

You're a scientist, so of course you have questions- Don't hesitate to contact us!